Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v1-EN
Language English English
Date Updated 2021-09-08 2021-09-07
Drug Identification Number 02472171 02472171
Brand name ATROPINE SULFATE INJECTION USP ATROPINE SULFATE INJECTION USP
Common or Proper name ATROPINE SULFATE INJECTION USP ATROPINE SULFATE INJECTION USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients ATROPINE SULFATE ATROPINE SULFATE
Strength(s) 0.5MG 0.5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 5mL 5mL x 10
ATC code A03BA A03BA
ATC description BELLADONNAAND DERIVATIVES, PLAIN BELLADONNAAND DERIVATIVES, PLAIN
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-09-07 2021-09-07
Remaining supply date 2021-09-07 2021-09-07
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments